LIGELIZUMAB ACHIEVES FREEDOM FROM DISEASE ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA REGARDLESS OF PREVIOUS H1-ANTIHISTAMINE DOSE

被引：0
|
作者：
Soong, W.
Sitz, K.
Bernstein, J.
Maurer, M.
Gimenez-Arnau, A.
Hua, E.
Severin, T.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2021年 / 127卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P049
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [1] Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine
    Curtortorto-Barredo, Laia
    Gimenez-Arnau, Ana M.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2019, 154 (04): : 444 - 456
  • [2] Ligelizumab Achieves Freedom from Signs and Symptoms of Chronic Spontaneous Urticaria Regardless of the CU Index (Basophil Histamine Release Assay) Status at Baseline
    Sitz, Karl
    Bernstein, Jonathan
    Soong, Weily
    Maurer, Marcus
    Gimenez-Arnau, Ana Maria
    Hua, Eva
    Severin, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB179 - AB179
  • [3] Neutrophil/Lymphocyte Ratio as a Biomarker of Response to H1-Antihistamine Therapy in Patients with Chronic Spontaneous Urticaria
    Qiu, Xiaonan
    Ran, Qiao
    Pan, Juanjuan
    Tan, Guozhen
    INDIAN JOURNAL OF DERMATOLOGY, 2024, 69 (05) : 367 - 370
  • [4] Patients treated with ligelizumab achieve freedom fromsigns and symptoms of chronic spontaneous urticaria regardless of the angioedema status at baseline
    Sitz, Karl
    Soong, Weily
    Bernstein, Jonathan A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB90 - AB90
  • [5] Ligelizumab achieves sustained symptom control up to 1 year in the majority of patients with chronic spontaneous urticaria
    Bernstein, J.
    Baker, D.
    Maurer, M.
    Gimenez-Arnau, A.
    Sussman, G.
    Manetsch, M.
    Barve, A.
    Hua, E.
    Severin, T.
    Janocha, R.
    SWISS MEDICAL WEEKLY, 2021, 151 : 11S - 12S
  • [6] H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects - A Retrospective Survey Study
    Weller, Karsten
    Ziege, Claudia
    Staubach, Petra
    Brockow, Knut
    Siebenhaar, Frank
    Krause, Karoline
    Altrichter, Sabine
    Church, Martin K.
    Maurer, Marcus
    PLOS ONE, 2011, 6 (09):
  • [7] Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H1-antihistamine dose escalation
    Magerl, M.
    Pisarevskaja, D.
    Staubach, P.
    Martus, P.
    Church, M. K.
    Maurer, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (05) : 1095 - 1099
  • [8] Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study
    Berard, F.
    Le Bouedec, M. C. Ferrier
    Bouillet, L.
    Reguiai, Z.
    Barbaud, A.
    Cambazard, F.
    Milpied, B.
    Pelvet, B.
    Kasujee, I.
    Gharbi, H.
    Lacour, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 56 - 66
  • [9] Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial
    Staevska, M.
    Gugutkova, M.
    Lazarova, C.
    Kralimarkova, T.
    Dimitrov, V.
    Zuberbier, T.
    Church, M. K.
    Popov, T. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) : 148 - 154
  • [10] In Chronic Spontaneous Urticaria, Complete Response to Antihistamine Treatment Is Linked to Low Disease Activity
    Turk, Murat
    Ertas, Ragip
    Sahiner, Umit Murat
    Kolkhir, Pavel
    Sekerel, Bulent Enis
    Soyer, Ozge
    Avci, Atil
    Atasoy, Mustafa
    Ozyurt, Kemal
    Turk, Yekta
    Zeydan, Engin
    Maurer, Marcus
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (05) : 421 - 432
12345